Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences NGS, SCA, Mass Spec: The Road to Diagnostics

Shaun Lonergan's Biography



Shaun Lonergan, Vice President/General Manager, Metabolon Inc

Shaun Lonergan is Vice President and General Manager of Precision Medicine at Metabolon, Inc. His past experience includes commercialization of several major research and diagnostic instrument platforms. Mr. Lonergan participated in or led successful sale or public offering of several companies while holding senior management positions at Boehringer Mannheim (Roche), Perceptive Biosystems (Thermo), Third Wave Technologies (Hologic), NimbleGen (Roche), 454 Life Sciences (Roche), Ibis Biosciences (Abbott Molecular) and Seegene, Inc. He served as CEO of Nerites Corporation (DSM), attaining more than $7 million in grant awards. Earlier, he was the clinical director at Oncology Laboratory, Inc. leading the in-vitro chemosensitivity assay clinical team. Mr. Lonergan earned his Master of Science degree in microbiology from the University of Rhode Island.

Shaun Lonergan Image

Metabolomics: The Missing Link in Precision Medicine

Wednesday, 30 September 2015 at 14:00

Add to Calendar ▼2015-09-30 14:00:002015-09-30 15:00:00Europe/LondonMetabolomics: The Missing Link in Precision MedicineNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Metabolon has developed a platform technology capitalizing on advances in mass spectrometry, proprietary software and database analysis to provide unprecedented insight into biochemical pathways. Along with information provided by whole genome or exome sequencing technologies, metabolite data provides ontology for determining genome wide associations.  This insight is critical to determining penetrance of a gene determinant of interest and relating it to health status.   Because metabolites are more closely linked to actionable information, metabolomics can provide clinicians with more insight to the patient’s health status.  With or without genetic information, metabolomics will play a big role in the future of precision medicine.


Add to Calendar ▼2015-09-28 00:00:002015-09-30 00:00:00Europe/LondonNGS, SCA, Mass Spec: The Road to DiagnosticsNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com